{"id":"saber-bupivacaine","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Paresthesia"}]},"_chembl":{"chemblId":"CHEMBL1098","moleculeType":"Small molecule","molecularWeight":"288.44"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By blocking nerve impulses, SABER-Bupivacaine provides prolonged pain relief. This is achieved through the sustained release of bupivacaine from a biodegradable polymer matrix.","oneSentence":"SABER-Bupivacaine is a sustained-release formulation of bupivacaine, a local anesthetic that blocks nerve impulses.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:33:12.552Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Postoperative pain management"}]},"trialDetails":[{"nctId":"NCT01139866","phase":"","title":"An Extension Trial to Evaluate Long-term Safety of SABER™-Bupivacaine for Pain Following Shoulder Surgery","status":"COMPLETED","sponsor":"Durect","startDate":"2010-06","conditions":"Pain","enrollment":47},{"nctId":"NCT02574520","phase":"PHASE3","title":"Trial of Extended Release Bupivacaine for Pain Relief After Surgery","status":"COMPLETED","sponsor":"Durect","startDate":"2015-11","conditions":"Post Operative Pain","enrollment":399},{"nctId":"NCT00993798","phase":"PHASE2","title":"An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Following Arthroscopic Shoulder Surgery","status":"COMPLETED","sponsor":"Durect","startDate":"2009-04","conditions":"Postoperative Pain","enrollment":107},{"nctId":"NCT01052012","phase":"PHASE3","title":"Bupivacaine Effectiveness and Safety in SABER® Trial","status":"COMPLETED","sponsor":"Durect","startDate":"2009-12","conditions":"Postoperative Pain, Abdominal Surgery","enrollment":331},{"nctId":"NCT00818363","phase":"PHASE2","title":"A Safety and Effectiveness Study of SABER®-Bupivacaine for Pain Following Shoulder Surgery","status":"COMPLETED","sponsor":"Durect","startDate":"2008-12","conditions":"Postoperative Pain","enrollment":60},{"nctId":"NCT00993226","phase":"PHASE2","title":"An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Undergoing Hysterectomy","status":"COMPLETED","sponsor":"Durect","startDate":"2009-05","conditions":"Postoperative Pain","enrollment":115},{"nctId":"NCT00974350","phase":"PHASE2","title":"A Safety and Efficacy Study of SABER®-Bupivacaine for Pain Following Hernia Repair","status":"COMPLETED","sponsor":"Durect","startDate":"2007-01","conditions":"Postoperative Pain, Hernia, Surgery","enrollment":124}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["POSIMIR® bupivacaine solution"],"phase":"phase_3","status":"active","brandName":"SABER-Bupivacaine","genericName":"SABER-Bupivacaine","companyName":"Durect","companyId":"durect","modality":"Small molecule","firstApprovalDate":"","aiSummary":"SABER-Bupivacaine is a sustained-release formulation of bupivacaine, a local anesthetic that blocks nerve impulses. Used for Postoperative pain management.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}